menu
    • menu

    Company profile for Symphogen

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Symphogen’s strategic priority is to commercialize our powerful research, preclinical and early development platform with the aim of establishing Symphogen as a preferred partner for the discovery and development of highly differentiated antibody therapeutics, either as combination or stand-alone therapies.As an affiliate of Servier our strategic focus is to apply our highly effective antibody platform and capabilities in th...
    Symphogen’s strategic priority is to commercialize our powerful research, preclinical and early development platform with the aim of establishing Symphogen as a preferred partner for the discovery and development of highly differentiated antibody therapeutics, either as combination or stand-alone therapies.As an affiliate of Servier our strategic focus is to apply our highly effective antibody platform and capabilities in the discovery and early development of highly differentiated antibody therapeutics, either as combination or stand-alone therapies supporting Servier’s R&D strategy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SymphogenDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Symphogen A/S Pederstrupvej 93 DK-2750 Ballerup Denmark
    Telephone
    Telephone
    +45 4526 5050
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.symphogen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Specifica Announces Agreement with Servier and its Subsidiary Symphogen
    Specifica Announces Agreement with Servier and its Subsidiary Symphogen

    29 Mar 2023

    // PRESS RELEASE

    https://servier.com/en/newsroom/specifica-antibody-discovery-platform-transfer-agreement-servier-symphogen/

    PRESS RELEASE
    29 Mar 2023
    Share Share
    Thermo Fischer Scientific and Symphogen Extend Collaboration
    Thermo Fischer Scientific and Symphogen Extend Collaboration

    01 Mar 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-03-01/thermo-fischer-scientific-and-symphogen-extend-collaboration/?widget=listSection

    CONTRACTPHARMA
    01 Mar 2022
    Share Share
    Thermo Fisher, Symphogen Extend Development Pact
    Thermo Fisher, Symphogen Extend Development Pact

    30 Oct 2020

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-10-29/thermo-fisher-symphogen-extend-development-pact/

    CONTRACTPHARMA
    30 Oct 2020
    Share Share
    Thermo Fisher, Symphogen Extend Development Pact
    Thermo Fisher, Symphogen Extend Development Pact

    29 Oct 2020

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-10-29/thermo-fisher-symphogen-extend-development-pact/

    CONTRACT PHARMA
    29 Oct 2020
    Share Share
    SERVIER COMPLETES THE ACQUISITION OF SYMPHOGEN
    SERVIER COMPLETES THE ACQUISITION OF SYMPHOGEN

    04 Jun 2020

    // PRESS RELEASE

    https://servier.com/en/news/servier-completes-acquisition-symphogen/#:~:text=Symphogen%2C%20a%20Danish%20biotechnology%20company,various%20therapeutic%20areas%2C%20including%20oncology.

    PRESS RELEASE
    04 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search